Literature DB >> 14580164

CYP3A4 and MDR1 alleles in a Portuguese population.

Isa Cavaco1, J Pedro Gil, Eva Gil-Berglund, Vera Ribeiro.   

Abstract

Polymorphisms in cytochrome P450 CYP3A4 and multidrug resistance (MDR) 1 genes coding for the important drug-metabolising CYP3A4 and the ATP-binding cassette (ABC) transporter P-glycoprotein (Pgp) are poorly documented in the Portuguese population. In this study we have determined the frequencies of CYP3A4 and MDR1 alleles in Portuguese Caucasians. Both genes were simultaneously analysed as these genes are known to be frequently co-induced and their products to show a pronounced overlap of substrates. CYP3A4 A-392G (CYP3A4*1B), T673C (CYP3A4*2) and MDR1 T-129C, G2677T and C3435T single nucleotide polymorphisms (SNPs) were analysed in 100 individuals from the southern region of the country. We observed a frequency of 4.0% for CYP3A4*1B, not significantly different from that reported on other Caucasian European populations. CYP3A4*2 was found at an allele frequency of 4.5%, constituting the first report of the presence of this allele outside the Finnish population. Significant differences were found concerning the MDR1 C3435T SNP frequency (64.5%) compared with other European populations, while no differences were found concerning G2677T (47.5%) or T-129C (5%) SNPs. Linkage between the C3435T and G2677T SNPs was observed, although not as evidently as documented in other Caucasian populations. No preferential associations were detected between CYP3A4 and MDR1 alleles.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14580164     DOI: 10.1515/CCLM.2003.206

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  8 in total

Review 1.  Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.

Authors:  Ron H N van Schaik
Journal:  Invest New Drugs       Date:  2005-12       Impact factor: 3.850

2.  Genetic variability and haplotype profile of MDR1 in Saudi Arabian males.

Authors:  Abdullah M Al-Mohizea; Khalid M Alkharfy; Khawla M Bagulb; Amal M Alghamdi; Fahad I Al-Jenoobi; Saleh Al-Muhsen; Rabih Halwani; Mohammad Khalid Parvez; M Khalid Parvez; Mohammed S Al-Dosari
Journal:  Mol Biol Rep       Date:  2012-10-07       Impact factor: 2.316

3.  The frequency of C3435T MDR1 gene polymorphism in Iranian patients with ulcerative colitis.

Authors:  Alma Farnood; Nosratollah Naderi; Seyed Javad Mirhasani Moghaddam; Babak Noorinayer; Farzad Firouzi; Rahim Aghazadeh; Nasser Ebrahimi daryani; Mohammad Reza Zali
Journal:  Int J Colorectal Dis       Date:  2007-01-23       Impact factor: 2.571

4.  Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam.

Authors:  M I Veiga; S Asimus; P E Ferreira; J P Martins; I Cavaco; V Ribeiro; T N Hai; M G Petzold; A Björkman; M Ashton; J P Gil
Journal:  Eur J Clin Pharmacol       Date:  2008-11-01       Impact factor: 2.953

5.  Ethnic differences in the prevalence of polymorphisms in CYP7A1, CYP7B1 AND CYP27A1 enzymes involved in cholesterol metabolism.

Authors:  Vera Dias; V Ribeiro
Journal:  J Pharm Bioallied Sci       Date:  2011-07

6.  Association of MDR1 gene SNPs and haplotypes with the tacrolimus dose requirements in Han Chinese liver transplant recipients.

Authors:  Xiaobo Yu; Haiyang Xie; Bajin Wei; Min Zhang; Weilin Wang; Jian Wu; Sheng Yan; Shusen Zheng; Lin Zhou
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

7.  The drug transporter ABCB1 c.3435C>T SNP influences artemether-lumefantrine treatment outcome.

Authors:  Kinanga Kiaco; António Sebastião Rodrigues; Virgílio do Rosário; José Pedro Gil; Dinora Lopes
Journal:  Malar J       Date:  2017-09-21       Impact factor: 2.979

8.  Association of MDR1 gene polymorphisms with the risk of hepatocellular carcinoma in the Chinese Han population.

Authors:  Jian Gao
Journal:  Braz J Med Biol Res       Date:  2013-03-15       Impact factor: 2.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.